The Automated Patch Clamp System Market is estimated to be valued at US$ 503.32 Mn or Mn in 2023 and is expected to exhibit a CAGR of 11.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
An automated patch clamp system is a technology used for electrophysiology studies to measure the electrical activity of living cells. Automated patch clamping techniques allow measurements of single ion channel currents or whole-cell currents in automated, parallelized assays. It has key applications in drug screening, safety pharmacology, and ion channel research. Different types of automated patch clamp systems available are voltage clamp, current clamp and hybrid clamp systems.
Market Dynamics:
Rising focus on drug discovery and development activities is a key driver for the automated patch clamp system market growth. Pharmaceutical and biotechnology companies are increasingly investing in high throughput screening techniques like patch clamping to expedite drug discovery and screening procedures. Additionally, growing incidence of target diseases like cardiac conditions and neurological disorders is also fueling demand for new drug molecules, propelling market expansion. Furthermore, technological advancements introducing Miniaturized, high throughput systems with improved capabilities is widening the scope of applications and adoption rate of automated patch clamp systems.
Segment Analysis
The automated patch clamp system market is dominated by the equipment segment. Equipment segment is further categorized as integrated system and accessory. The integrated system sub-segment dominates the equipment segment as it is built with various components which are pre-installed and integrated into automated workstations. This integration of components reduces errors and enhances productivity.
PEST Analysis
Political: Regulations regarding laboratory safety and toxicity testing have boosted the adoption of automated patch clamp systems. Economic: Increasing R&D investments in pharmaceutical and biotechnology industries and rising drug development activities have fueled market growth. Social: Growing geriatric population and high incidence of chronic diseases have created demand for new drugs, propelling the adoption of automated patch clamp systems. Technological: Advancements in miniaturized sensor technology and automation have facilitated high-throughput screening, driving the automated patch clamp system market.
Key Takeaways
The Global Automated Patch Clamp System Market Demand is expected to witness high growth, exhibiting a CAGR of 11% over the forecast period, due to increasing R&D investments in drug development. The equipment segment accounts for the largest share of the market owing to rising adoption of integrated systems for their error reduction and enhanced productivity capabilities.
Regionally, North America dominated the automated patch clamp system market and is expected to continue its dominance during the forecast period. This is attributed to presence of major players and extensive research activities in the region. Asia Pacific is anticipated to witness fastest growth due to rising biotech hubs, expansion of pharmaceutical industries and growing government support for drug development.
Key players operating in the automated patch clamp system market are Sophion Bioscience A/S, Nanion Technologies GmbH, NeoBiosystems, Inc., Multi Channel Systems MCS GmbH, Fluxion Biosciences, Molecular Devices, LLC, Scitech Korea Inc., and HEKA Elektronik GmbH. These players are focused on developing advanced products and expanding in lucrative markets to strengthen their market position.
Read More:
